Gene Modified T Cell Therapies for Hematological Malignancies

被引：5
|
作者：
Abramowski-Mock, Ulrike [1 ]
Delhove, Juliette M. [1 ]
Qasim, Waseem [1 ]
机构：
[1] UCL, Mol & Cellular Immunol Unit, UCL Great Ormond St Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2017年 / 31卷 / 05期
基金：
“创新英国”项目;
关键词：
Gene therapy; Gene editing; Adoptive immunotherapy; T cell receptor; Chimeric antigen receptor; Lentiviral vectors; Leukemia; Lymphoma; CHIMERIC-ANTIGEN-RECEPTOR; ACUTE MYELOID-LEUKEMIA; ZINC-FINGER NUCLEASES; B-CELL; CANCER-IMMUNOTHERAPY; ADOPTIVE IMMUNOTHERAPY; IMMUNE CHECKPOINTS; MULTIPLE-MYELOMA; CLINICAL-TRIAL; LYMPHOCYTES;
D O I：
10.1016/j.hoc.2017.06.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This article focuses on clinical applications of T cells transduced to express recombinant T-cell receptor and chimeric antigen receptor constructs directed toward hematological malignancies, and considers newer strategies incorporating gene-editing technologies to address graft-versus-host disease and host-mediated rejection. Recent data from clinical trials are reviewed, and an overview is provided of current and emerging manufacturing processes; consideration is also given to new developments in the pipeline.
引用
收藏
页码：913 / +
页数：15
相关论文
共 50 条
  • [41] Off the shelf T cell therapies for hematologic malignancies
    McCreedy, Bruce J.
    Senyukov, Vladimir V.
    Nguyen, Kim T.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (02) : 166 - 175
  • [42] The Evolution of T-cell Therapies for Solid Malignancies
    Fousek, Kristen
    Ahmed, Nabil
    CLINICAL CANCER RESEARCH, 2015, 21 (15) : 3384 - 3392
  • [43] The roles of stem cell memory T cells in hematological malignancies
    Xu, Ling
    Zhang, Yikai
    Luo, Gengxin
    Li, Yangqiu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [44] The Impact of CAR T-Cell Therapy on Hematological Malignancies
    Park, Jae
    ONCOLOGY-NEW YORK, 2024, 38 (03):
  • [45] The roles of stem cell memory T cells in hematological malignancies
    Ling Xu
    Yikai Zhang
    Gengxin Luo
    Yangqiu Li
    Journal of Hematology & Oncology, 8
  • [46] Cytokine Release Syndrome Associated with T-Cell-Based Therapies for Hematological Malignancies: Pathophysiology, Clinical Presentation, and Treatment
    Cosenza, Maria
    Sacchi, Stefano
    Pozzi, Samantha
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [47] Optimization of the HA-1-Specific T Cell Receptor for Gene Therapy of Hematological Malignancies.
    van Loenen, Marleen M.
    Hagedoorn, Renate S.
    de Boer, Renate
    van Egmond, Esther M.
    Willemze, Roelof
    Falkenburg, J. H. Frederik
    Heemskerk, Mirjam H. M.
    BLOOD, 2009, 114 (22) : 1570 - 1570
  • [48] Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies
    Little, Jessica S.
    Weiss, Zoe F.
    Hammond, Sarah P.
    JOURNAL OF FUNGI, 2021, 7 (12)
  • [49] Apoptosis-based therapies for hematological malignancies.
    Alenzi, FQB
    CLINICAL IMMUNOLOGY, 2005, 115 : S175 - S175
  • [50] Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
    Schuette, Judith
    Reusch, Julia
    Khandanpour, Cyrus
    Eisfeld, Christine
    FRONTIERS IN ONCOLOGY, 2019, 9
12345